C1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft Rejection
Clinical trial NCT02936479 · COMPLETED
Trial details
- NCT number
- NCT02936479
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-10-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.